• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境、内分泌干扰物与代谢功能障碍相关脂肪性肝病(MASLD)

Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD).

作者信息

Mosca Antonella, Manco Melania, Braghini Maria Rita, Cianfarani Stefano, Maggiore Giuseppe, Alisi Anna, Vania Andrea

机构信息

Hepatology and Liver Transplant Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Preventive and Predictive Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Metabolites. 2024 Jan 22;14(1):71. doi: 10.3390/metabo14010071.

DOI:10.3390/metabo14010071
PMID:38276306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10819942/
Abstract

Ecological theories suggest that environmental factors significantly influence obesity risk and related syndemic morbidities, including metabolically abnormal obesity associated with nonalcoholic fatty liver disease (MASLD). These factors encompass anthropogenic influences and endocrine-disrupting chemicals (EDCs), synergistically interacting to induce metabolic discrepancies, notably in early life, and disrupt metabolic processes in adulthood. This review focuses on endocrine disruptors affecting a child's MASLD risk, independent of their role as obesogens and thus regardless of their impact on adipogenesis. The liver plays a pivotal role in metabolic and detoxification processes, where various lipophilic endocrine-disrupting molecules accumulate in fatty liver parenchyma, exacerbating inflammation and functioning as new anthropogenics that perpetuate chronic low-grade inflammation, especially insulin resistance, crucial in the pathogenesis of MASLD.

摘要

生态学理论表明,环境因素会显著影响肥胖风险及相关综合征性疾病,包括与非酒精性脂肪性肝病(MASLD)相关的代谢异常肥胖。这些因素包括人为影响和内分泌干扰化学物质(EDC),它们协同作用,诱发代谢差异,尤其是在生命早期,并扰乱成年期的代谢过程。本综述聚焦于影响儿童MASLD风险的内分泌干扰物,独立于它们作为致肥胖物的作用,因此不论其对脂肪生成的影响。肝脏在代谢和解毒过程中起关键作用,各种亲脂性内分泌干扰分子在脂肪肝实质中蓄积,加剧炎症,并作为新的人为因素使慢性低度炎症持续存在,尤其是胰岛素抵抗,这在MASLD发病机制中至关重要。

相似文献

1
Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD).环境、内分泌干扰物与代谢功能障碍相关脂肪性肝病(MASLD)
Metabolites. 2024 Jan 22;14(1):71. doi: 10.3390/metabo14010071.
2
The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review.内分泌干扰化学物质与表观基因组之间对代谢功能障碍相关脂肪性肝病的相互作用:综述
Nutrients. 2024 Apr 11;16(8):1124. doi: 10.3390/nu16081124.
3
The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.内分泌干扰物在胰岛素抵抗发病机制中的新作用:一个暗示非酒精性脂肪性肝病的概念。
Curr Mol Med. 2012 Jan;12(1):68-82. doi: 10.2174/156652412798376161.
4
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.代谢功能障碍相关脂肪性肝病相关肝肿瘤的病理学与发病机制
Biomedicines. 2023 Oct 12;11(10):2761. doi: 10.3390/biomedicines11102761.
5
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.代谢功能障碍相关脂肪性肝病/非酒精性脂肪性肝病与2型糖尿病的关联:巴基斯坦一家三级医疗医院的病例对照研究
Cureus. 2023 Oct 17;15(10):e47240. doi: 10.7759/cureus.47240. eCollection 2023 Oct.
6
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病(MASLD)和代谢功能障碍相关脂肪性肝炎(MASH)对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
7
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
8
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.代谢功能障碍相关脂肪性肝病(MASLD)的内分泌方面:超越胰岛素抵抗。
J Hepatol. 2023 Dec;79(6):1524-1541. doi: 10.1016/j.jhep.2023.08.030. Epub 2023 Sep 18.
9
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).打破障碍:肠道内稳态在代谢相关脂肪性肝病(MASLD)中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2331460. doi: 10.1080/19490976.2024.2331460. Epub 2024 Mar 21.
10
Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress.内分泌干扰化学物的肝和胰腺毒性:聚焦于线粒体功能障碍和氧化应激。
Int J Mol Sci. 2024 Jul 6;25(13):7420. doi: 10.3390/ijms25137420.

引用本文的文献

1
Ultra-Processed Foods and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): What Is the Evidence So Far?超加工食品与代谢功能障碍相关脂肪性肝病(MASLD):目前有哪些证据?
Nutrients. 2025 Jun 24;17(13):2098. doi: 10.3390/nu17132098.
2
Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease.脂肪组织作为环境毒物的作用靶点:聚焦代谢功能障碍相关脂肪性肝病中的线粒体功能障碍和氧化炎症
Mol Cell Biochem. 2025 May;480(5):2863-2879. doi: 10.1007/s11010-024-05165-z. Epub 2024 Dec 20.
3
Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress.

本文引用的文献

1
Bisphenol A induces non-alcoholic fatty liver disease by promoting the O-GlcNAcylation of NLRP3.双酚A通过促进NLRP3的O-连接N-乙酰葡糖胺化诱导非酒精性脂肪性肝病。
Arch Physiol Biochem. 2024 Dec;130(6):814-822. doi: 10.1080/13813455.2023.2288533. Epub 2023 Dec 1.
2
Green tea polyphenols alleviate di-(2-ethylhexyl) phthalate-induced liver injury in mice.绿茶多酚减轻小鼠邻苯二甲酸二(2-乙基己基)酯诱导的肝损伤。
World J Gastroenterol. 2023 Sep 14;29(34):5054-5074. doi: 10.3748/wjg.v29.i34.5054.
3
Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
内分泌干扰化学物的肝和胰腺毒性:聚焦于线粒体功能障碍和氧化应激。
Int J Mol Sci. 2024 Jul 6;25(13):7420. doi: 10.3390/ijms25137420.
4
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques.运用机器学习技术探讨代谢综合征和脂肪性肝病对肝细胞癌的预后影响
Metabolites. 2024 May 27;14(6):305. doi: 10.3390/metabo14060305.
5
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression.TCPOBOP 激活的肝组成型雄烷受体诱导的脂肪变性肝病:与疾病进展相关的原发性和继发性基因反应。
Toxicol Sci. 2024 Aug 1;200(2):324-345. doi: 10.1093/toxsci/kfae057.
解析镉、铅、砷和汞在非酒精性脂肪肝和非酒精性脂肪性肝炎中的作用。
Environ Res. 2023 Dec 1;238(Pt 1):117134. doi: 10.1016/j.envres.2023.117134. Epub 2023 Sep 13.
4
The Effect of Individual or Study-Wide Report-Back on Knowledge, Concern, and Exposure-Reducing Behaviors Related to Endocrine-Disrupting Chemicals.个体或研究范围报告反馈对与内分泌干扰化学物质相关的知识、关注和减少暴露行为的影响。
Environ Health Perspect. 2023 Sep;131(9):97005. doi: 10.1289/EHP12565. Epub 2023 Sep 8.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
6
TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule.2,3,7,8-四氯二苯并对二恶英对长链非编码RNA表达、肝小叶区域化以及肝小叶内细胞间通讯的失调作用。
Toxicol Appl Pharmacol. 2023 Jul 15;471:116550. doi: 10.1016/j.taap.2023.116550. Epub 2023 May 11.
7
Liver Transplantation 2023: Status Report, Current and Future Challenges.肝脏移植 2023:现状报告、当前和未来的挑战。
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2150-2166. doi: 10.1016/j.cgh.2023.04.005. Epub 2023 Apr 20.
8
Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease.内分泌干扰化学物质:非酒精性脂肪性肝病的促进因素。
Front Public Health. 2023 Mar 22;11:1154837. doi: 10.3389/fpubh.2023.1154837. eCollection 2023.
9
The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey.内分泌干扰化学物质与 MAFLD 的关联:来自 NHANES 调查的证据。
Ecotoxicol Environ Saf. 2023 May;256:114836. doi: 10.1016/j.ecoenv.2023.114836. Epub 2023 Mar 29.
10
Endocrine-Disrupting Chemicals and Disease Endpoints.内分泌干扰化学物质与疾病终点
Int J Mol Sci. 2023 Mar 10;24(6):5342. doi: 10.3390/ijms24065342.